Healthcare, Financials, Automotive Dec 28, 2021 05:39 PM (GMT+8) · EqualOcean
Financial Associated Press, Dec. 28 - Fosun Pharmaceutical announced that Ningbo Fuying, the company's holding subsidiary, and Sinopharm CICC plan to jointly contribute to the establishment of a target fund, which is specially used for the investment in Chenxi health. The target fund plans to raise 11.11 million yuan, of which Ningbo Fuying (as LP) and Sinopharm Zhongjin (as GP) plan to contribute 10 million yuan and 1.11 million yuan in cash to subscribe for the equivalent property shares of the target fund.